MEDICAL RECOMMENDATIONS

Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults

National Advisory Committee on ImmunizationImmunization2022Archived document

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults”. Summary of NACI updates on the use of Moderna Spikevax BA.4/5 bivalent mRNA COVID-19 booster vaccine in adults.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document